Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -525,192 | 151,118 | -55,783 | 141,999 | 89,792 |
| Depreciation Amortization | 800,315 | 86,411 | 82,586 | 90,117 | 43,930 |
| Income taxes - deferred | 7,872 | -12,510 | 4,035 | -39,230 | 8,018 |
| Accounts receivable | -11,171 | -492 | -18,961 | -14,315 | -8,568 |
| Accounts payable and accrued liabilities | 8,321 | 2,076 | -2,586 | 2,248 | -79 |
| Other Working Capital | -32,599 | 18,931 | -58,618 | -7,723 | 16,026 |
| Other Operating Activity | 28,020 | 46,793 | 225,300 | 43,688 | 30,960 |
| Operating Cash Flow | $275,566 | $292,327 | $175,973 | $216,784 | $180,079 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -198,642 | -230,938 | -181,617 | -94,388 | -43,308 |
| Net Acquisitions | -69,151 | -11,584 | -30,862 | -3,400 | -571,992 |
| Purchase Of Investment | -6,439 | -299,408 | -207,900 | -15,580 | -16,689 |
| Sale Of Investment | 45,444 | 334,546 | 122,981 | 405 | 32,621 |
| Other Investing Activity | 51 | 2,668 | 0 | 0 | 0 |
| Investing Cash Flow | $-228,737 | $-204,716 | $-297,398 | $-112,963 | $-599,368 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 102,000 | N/A | 440,300 | 133,700 | 594,000 |
| Debt Repayment | -36,540 | -64,545 | -170,842 | -337,305 | -173,862 |
| Common Stock Issued | 28,141 | 53,977 | 22,900 | 27,123 | 26,554 |
| Common Stock Repurchased | -115,058 | -41,617 | -249,958 | -17,997 | N/A |
| Dividend Paid | N/A | N/A | N/A | -1,400 | -2,112 |
| Other Financing Activity | 3,788 | 5,758 | -36,832 | 639 | -7,449 |
| Financing Cash Flow | $-17,669 | $-46,427 | $5,568 | $-195,240 | $437,131 |
| Exchange Rate Effect | -17,310 | 13,032 | -1,205 | -17,878 | 3,429 |
| Beginning Cash Position | 225,449 | 175,380 | 114,821 | 207,566 | 182,331 |
| End Cash Position | 243,592 | 225,449 | 175,380 | 114,821 | 207,566 |
| Net Cash Flow | $18,143 | $50,069 | $60,559 | $-92,745 | $25,235 |
| Free Cash Flow | |||||
| Operating Cash Flow | 275,566 | 292,327 | 175,973 | 216,784 | 180,079 |
| Capital Expenditure | -198,642 | -230,938 | -181,747 | -94,520 | -44,735 |
| Free Cash Flow | 76,924 | 61,389 | -5,774 | 122,264 | 135,344 |